Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a China-based company principally engaged in the research, development, manufacturing and retail of Chinese herbal medicines, Chinese patent medicines, chemical raw materials and preparations, and nutritional health products. The Company operates its businesses through three segments. The Chinese Patent Medicine segment is mainly engaged in the research, development, manufacturing and sales of Chinese medicines, including Su Xiao Jiu Xin Pill, Jing Wan Hong Ruan Gao, An Gong Niu Huang Pill, Qing Gong Shou Tao Pill and other products. The Western Medicine segment is mainly engaged in the research, development, manufacturing and sales of Western medicines. The Others segment mainly includes economic information consulting services, house leasing and other businesses. The Company mainly operates its businesses in the domestic and overseas markets.

Employees

3,890

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
26-08-28	CN¥36.43	+0.08%	1,328,757
26-08-27	CN¥36.40	-0.49%	1,914,600
26-08-26	CN¥36.58	+1.39%	2,774,074
26-08-25	CN¥36.08	+1.01%	1,841,912
26-08-24	CN¥35.72	+1.05%	2,780,150

End-of-day quote Shanghai S.E.

More quotes

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

36.43

Average target price

Consensus

EPS Estimates

Revisions to estimates

Annual profits - Rate of surprise

Company calendar

End-of-day quote Shanghai S.E. 2026-08-28			5-day change	1st Jan Change
36.43 ^CNY	+0.08%		+3.06%	-20.14%

08-14	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2026	CI
08-10	Tianjin Pharmaceutical Gets China Nod for Diabetes Combo Drug	MT

Market Cap	24.19B 3.59B 3.1B 2.9B 2.65B 4.99B 344B 5.01B 34.46B 13.44B 173B 13.5B 13.2B 575B	P/E 2026 *	27.2x	P/E 2027 *	23.7x
Enterprise Value	24.19B 3.59B 3.1B 2.9B 2.65B 4.99B 344B 5.01B 34.46B 13.44B 173B 13.5B 13.2B 575B	EV / Sales 2026 *	4.9x	EV / Sales 2027 *	4.52x
Free-Float	31.71%	Yield 2026 *	-	Yield 2027 *	-

08-14	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Reports Earnings Results for the Half Year Ended June 30, 2026	CI
08-10	Tianjin Pharmaceutical Gets China Nod for Diabetes Combo Drug	MT
08-10	Tianjin Pharmaceutical Signs 113-Million-Yuan Distribution Deal	MT
08-09	Tianjin Pharmaceutical Unit Gets China's Nod for Diabetes Drug Registration	MT
08-09	Tianjin Pharmaceutical Da Ren Tang to Sign Warehousing Deal	MT
08-07	Xinxin Pharmaceutical Plant Receives Drug Registration Certificate for Saxagliptin and Metformin Hydrochloride Sustained-Release Tablets (I)	CI
08-07	Tianjin Pharmaceutical Da Ren Tang Secures China Nod for Diabetes Combo Drug	MT
07-14	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Provides Earnings Guidance for the Six Months Ended 30 June 2026	CI
07-14	Tianjin Pharmaceuticals Warns of Up to 68% Plunge in H1 Profit	MT
06-25	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Approves Adjustments to the Composition of the Respective Board Committees	CI
05-20	Chinese State-Backed Entities to Dispose of Stake in Tianjin Pharmaceutical Da Ren Tang Unit via Public Tender	MT
05-15	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Appointment of Zhai Shuping as Independent and Non-Executive Director, Effective May 15, 2026	CI
05-15	Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Cessation of Liew Yoke Pheng Joseph as Independnet and Non-Executive Director, Chairman of the Audit Committee and A Member of the Remuneration Committee	CI

24-09-30	Borsa di Italia: nuovi fuochi d'artificio sul mercato azionario cinese
24-09-30	Bolsa de Madrid: Nuevos fuegos artificiales bursátiles en China
24-09-30	En direct des marchés : Stellantis avertit, Volkswagen avertit, Aston Martin avertit
24-09-30	Nouveau feu d'artifice boursier en Chine

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock

Stocks

600329

CNE000001808

Pharmaceuticals

Valuation : Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Chart: Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Latest news : Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Press Releases : Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

News in other languages : Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Quotes and Performance

Price Extremes

Managers and Directors : Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Latest insider transactions

Alternative Medicine

Financials

Company Profile

Quotes

Analysts' Consensus

Annual profits - Rate of surprise

1 day	+0.08%
1 week	+3.06%
Current month	-4.86%
1 month	-4.38%
3 months	-10.54%
6 months	-15.30%
Current year	-20.14%

1 week	35.11	36.94
1 month	35.11	38.66
Current year	34.7	48.2
1 year	34.7	50.95
3 years	23.4	50.97
5 years	17.98	56.26
10 years	11.8	56.26

Manager	Title	Age	Since
Lei Wang CEO	Chief Executive Officer	55	2017-10-09
Hong Zhou PRN	Corporate Officer/Principal	56	-
Mai Wang PRN	Corporate Officer/Principal	56	-

Director	Title	Age	Since
Xiu Mei Guo BRD	Director/Board Member	44	2018-12-23
Mai Wang BRD	Director/Board Member	56	-
Hong Zhou BRD	Director/Board Member	56	2019-05-14

Date	Insider	Type	Main position	Quantity	% Market Cap.
1/8/20	Yan Jiao	Buy	Company Secretary	30,000	0.0053%
1/8/20	Hong Zhou	Buy	Chief Technology Officer	70,000	0.0124%
1/8/20	Hong Yu	Buy		70,000	0.0124%

	2026 *	2027 *
Net sales	4.93B 733M 632M 592M 541M 1.02B 70.05B 1.02B 7.03B 2.74B 35.36B 2.75B 2.69B 117B	5.35B 795M 685M 643M 587M 1.11B 76.01B 1.11B 7.62B 2.97B 38.37B 2.99B 2.92B 127B
Net income	1.04B 154M 133M 124M 114M 214M 14.72B 215M 1.48B 576M 7.43B 578M 566M 24.63B	1.18B 176M 152M 142M 130M 245M 16.82B 245M 1.69B 658M 8.49B 661M 646M 28.15B
Net Debt	-	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+0.08%	+3.06%	-20.99%	+4.99%	3.59B
YUNNAN BAIYAO GROUP CO.,LTD	+0.02%	+1.36%	-13.16%	-6.82%	13.26B
BEIJING TONGRENTANG CO., LTD	+0.53%	+2.99%	-31.39%	-57.20%	4.99B
DONG-E-E-JIAO CO., LTD.	+0.27%	+1.59%	-5.32%	-1.35%	4.66B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	-0.43%	-1.64%	-1.22%	-30.41%	4.02B
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	-0.67%	+2.71%	-2.98%	-5.08%	3.43B
TASLY PHARMACEUTICAL GROUP CO., LTD	+0.47%	-0.53%	-9.87%	+6.74%	3.31B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	-2.19%	-2.26%	-22.25%	-14.00%	2.38B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD.	+0.74%	+2.97%	-26.78%	-13.38%	1.72B
ZHEJIANG CONBA PHARMACEUTICAL CO.,LTD.	-0.22%	+4.17%	-0.66%	-12.45%	1.7B
Average	-0.14%	+2.40%	-13.46%	-12.90%	4.31B
Weighted average by Cap.	-0.05%	+1.93%	-13.46%	-12.98%